白血球分離術市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，白血球分離術市場規模將達到 847.1 億美元，到 2025 年將達到 922.5 億美元，到 2033 年將達到 1824.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 8.9%。

白血球分離術市場是醫療保健領域至關重要且充滿活力的細分市場，為多種疾病提供重要的治療和診斷解決方案。該過程包括從血液中選擇性地提取白血球，從而促進白血病、淋巴瘤、自體免疫疾病等疾病的治療和研究。市場成長的主要驅動力是血液疾病發病率的上升以及提高手術療效和安全性的技術創新。然而，醫療專業人員認知不足和高成本等挑戰可能會阻礙其廣泛應用。顯著的發展趨勢包括個人化醫療方法以及與其他療法的整合，而機會則在於免疫療法研究的拓展、精準醫療以及醫療基礎設施的改善，尤其是在發展中地區。

白血球分離術市場促進因素

血液疾病（包括白血病和淋巴瘤）的日益普遍是白血球分離術市場的主要驅動力。對有效治療方法這些疾病的需求促使白血球分離術的使用量增加，而白血球分離術對於控制白血球增多症至關重要。尤其是在急性白血病病例中，該療法可以迅速減少血液中的白血病細胞數量，這對於緩解患者症狀和後續治療性介入至關重要。隨著越來越多的患者被診斷出患有這些疾病，對白血球分離術的需求持續成長，凸顯了其在患者照護中的關鍵作用。

限制白血球分離術市場的因素

由於醫護人員和患者對白血球分離術的益處認知度較低，該療法市場面臨嚴峻挑戰。這種認知不足可能會阻礙市場擴張，並凸顯了進行全面教育和宣傳活動以推廣白血球分離術作為有效治療方案的必要性。此外，白血球分離術設備及其耗材的經濟負擔也構成了一項進入障礙，尤其是在資源匱乏的地區。雪上加霜的是，這些操作需要技術嫻熟的醫護人員來執行，這可能會限制白血球分離術在臨床環境中的廣泛應用。

白血球純化療法市場趨勢

白血球分離術市場的一個顯著趨勢是其與先進細胞療法（尤其是嵌合體抗原受體 (CAR) T 細胞療法）的融合。這種協同作用透過利用白血球分離術高效採集患者來源的白血球進行基因改造，增強了癌症治療的療效。隨著個人化醫療需求的日益成長，白血球分離術正成為最先進治療通訊協定的重要組成部分，有助於制定旨在改善患者預後的個人化治療策略。這種日益增強的相互依存關係正在推動白血球分離術市場的創新、投資和擴張，反映了腫瘤學實踐的變革性變化。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 案例研究

全球白血球分離術市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 一次性
• 裝置
  • 離心分離器
  • 膜分離設備

全球白血球分離術市場規模（按應用領域分類）及複合年成長率（2026-2033 年）

• 研究用途
• 治療用途

全球白血球分離術市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 血液成分供應商和血站
• 學術和研究機構
• 製藥和生物技術公司
• 醫院及輸血中心

全球白血球分離術市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Terumo BCT
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Asahi Kasei Corporation
• Macopharma SA
• Miltenyi Biotec
• Medica Spa
• Puriblood Medical Co. Ltd.
• Beijing ZKSK Technology Co. Ltd.
• SB-Kawasumi Laboratories, Inc.
• Nikkiso Co., Ltd.
• Charles River Laboratories International, Inc.
• Discovery Life Sciences, Inc.
• Precision for Medicine, Inc.
• StemExpress, LLC
• Lonza Group AG
• Caltag Medsystems Limited
• Stemcell Technologies
• Trina Bioreactives AG
• AcceGen
• First Choice Bio LLC

結論與建議

Leukapheresis Market size was valued at USD 84.71 Billion in 2024 and is poised to grow from USD 92.25 Billion in 2025 to USD 182.47 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The leukapheresis market represents a crucial and dynamic segment in the medical realm, offering essential therapeutic and diagnostic solutions for a range of diseases. This process involves the selective extraction of white blood cells from the bloodstream, fostering advancements in treatment and research for conditions like leukemia, lymphoma, and autoimmune disorders. The market's growth is primarily propelled by the rising incidence of hematologic disorders and technological innovations that enhance the procedure's efficacy and safety. However, challenges such as limited awareness among healthcare providers and high costs may impede access. Notable trends include personalized medicine approaches and integration with other therapies, while opportunities lie in expanding immunotherapy research, precision medicine, and improved healthcare infrastructure, particularly in developing regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Leukapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Leukapheresis Market Segments Analysis

Global Leukapheresis Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into Disposables, Devices. Based on Application, the market is segmented into Research Applications, Therapeutic Applications. Based on End User, the market is segmented into Blood component providers & blood centers, Academic & research institutes, Pharmaceutical & biotechnology companies, Hospitals & transfusion centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Leukapheresis Market

The growing prevalence of hematologic disorders, including leukemia and lymphoma, significantly propels the leukapheresis market. The need for effective treatment options to address these conditions has led to an increased utilization of leukapheresis, which is essential for managing elevated white blood cell counts. This procedure is particularly important in acute leukemia cases, where it can swiftly lower the number of leukemic cells in the bloodstream, thereby alleviating patient symptoms and facilitating the administration of subsequent therapeutic interventions. As more individuals are diagnosed with these disorders, the demand for leukapheresis continues to expand, underscoring its vital role in patient care.

Restraints in the Leukapheresis Market

The leukapheresis market faces significant challenges due to limited awareness among both healthcare providers and patients regarding the advantages of leukapheresis procedures. This lack of understanding can impede market expansion, highlighting the need for comprehensive education and awareness initiatives to promote leukapheresis as a viable treatment option. Additionally, the financial burden associated with leukapheresis devices and their consumables poses a barrier to accessibility, especially in areas with constrained resources. Furthermore, the requirement for skilled healthcare professionals to administer these procedures further complicates matters, potentially limiting the broader adoption of leukapheresis in clinical practice.

Market Trends of the Leukapheresis Market

The leukapheresis market is experiencing a notable trend towards its integration with advanced cell-based therapies, particularly chimeric antigen receptor (CAR) T-cell therapy. This synergy enhances the effectiveness of cancer treatments by utilizing leukapheresis for the efficient collection of patient-derived white blood cells necessary for genetic modifications. As the demand for personalized medicine escalates, leukapheresis is becoming an essential component of cutting-edge therapeutic protocols, enabling the development of tailored treatment strategies that aim to improve patient outcomes. This growing interdependence is driving innovation, investment, and expansion within the leukapheresis market, reflecting a transformative shift in oncology practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Leukapheresis Market Size by Type & CAGR (2026-2033)

• Market Overview
• Disposables
• Devices
  • Centrifugal Devices
  • Membrane Separators

Global Leukapheresis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Research Applications
• Therapeutic Applications

Global Leukapheresis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Blood component providers & blood centers
• Academic & research institutes
• Pharmaceutical & biotechnology companies
• Hospitals & transfusion centers

Global Leukapheresis Market Size & CAGR (2026-2033)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puriblood Medical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB-Kawasumi Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Discovery Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemExpress, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caltag Medsystems Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trina Bioreactives AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• First Choice Bio LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation